Loading IPHA charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading IPHA comparable companies…
| IPHAInnate Pharma SA(opens in a new tab) | $0.13B | $0.01B | −53.2% | — | −599.8% | 13.07× | — |
|---|---|---|---|---|---|---|---|
| CRBUCaribou Biosciences, Inc.(opens in a new tab) | $0.04B | $0.01B | +10.0% | — | −1090.9% | 4.26× | — |
| RLAYRelay Therapeutics, Inc.(opens in a new tab) | — | $0.01B | +23.9% | — | −2999.4% | — | — |
| SRZNSurrozen, Inc.(opens in a new tab) | $0.68B | $0.01B | −8.8% | — | −385.3% | 58.67× | — |
| ELUTElutia Inc.(opens in a new tab) | $0.04B | $0.01B | −0.3% | 57.8% | −214.9% | 3.05× | 0.8× |
| Medianpeers, excl. IPHA | $0.04B | $0.01B | +4.8% | 57.8% | −738.1% | 4.26× | 0.8× |